Skip to main content
Atrás
Watch Compare

Telomir Pharmaceuticals, Inc.

Calidad de datos: 83%
TELO
NASDAQ Manufacturing Chemicals
$1.34
$0.00 (0.00%)
6 months return
—
Momentum
Neutral
ROE
-279.15%

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-279.15%
Below sector avg (-54.68%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio17.51
Interest CoverageN/A

Valoración

PE (TTM)
-4.19
Below sector avg (-1.49)
P/B Ratio6.26
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -3.69 M

Price History

Tendencias Financieras

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Sorpresas de Ganancias

EPS
Reported Estimate
Q42024 Q12025 Q22025 Q32025
Reported -$0.10 -$0.07 -$0.17 -$0.03
Estimate -$0.05 -$0.10 -$0.08 -$0.07
Sorpresa -100.00% +30.00% -112.50% +57.14%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -279.15% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -10.41 M
ROE -279.15% ROA -253.00%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -3.69 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 17.51
Debt / Equity N/A Current Ratio 17.51
Interest Coverage N/A Asset Turnover N/A
Working Capital 6.98 M Tangible Book Value 6.98 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -4.19 · EV/EBITDA: N/A
P/E Ratio -4.19 Forward P/E N/A
P/B Ratio 6.26 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.45%
Market Cap 43.66 M Enterprise Value 43.66 M

Per Share

EPS: -0.33 · FCF/Share: -0.11
EPS (Diluted TTM) -0.33 Revenue / Share N/A
FCF / Share -0.11 OCF / Share -0.11
EPS CAGR (1Y) -158.93% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 35.42% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 35.42%
SBC-Adj. FCF -8.99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — — —
Net Income -10.41 M -16.53 M -13.07 M
EPS (Diluted) -0.33 0.56 -0.45
Gross Profit — — —
Operating Income — — —
EBITDA — — —
R&D Expenses 2.44 M 2.24 M 1.57 M
SG&A Expenses — — —
D&A — — —
Interest Expense 4.34 M 4.34 M 1.64 M
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 7.34 M 1.32 M 4.77 M
Total Liabilities 1.43 M 680,968.0 1.34 M
Shareholders' Equity 5.91 M 643,037.0 3.44 M
Total Debt — — —
Cash & Equivalents — — —
Current Assets 7.34 M 1.32 M 435,225.0
Current Liabilities 1.43 M 680,968.0 1.34 M

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -4.2 -1.5
P/B 6.3 1.6
ROE % -279.2 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3